Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550082 · ClinicalTrials.gov registry record
3 Screen Electronic Alert
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 880
- Enrollment target
NCT00550082: Completed study, sponsored by Brigham and Women's Hospital.
NCT00550082 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 880 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00550082 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 880 participants
- Enrollment target
Study Summary
Evaluation of physician responses to BICS-Clinical Information 3-screen alerts that informs the clinician that his/her patient may be eligible for thromboprophylaxis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 880 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-11 |
What the finished NCT00550082 record still lists
NCT00550082 is an observational study that tracks outcomes without assigning an intervention. The registered 880 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00550082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00550082 about?
NCT00550082 is a clinical study titled "3 Screen Electronic Alert". Evaluation of physician responses to BICS-Clinical Information 3-screen alerts that informs the clinician that his/her patient may be eligible for thromboprophylaxis.
What is the current status of trial NCT00550082?
This trial is currently completed. The enrollment target is 880 participants. The study started on 2007-07. Estimated completion is 2009-11.
Who is sponsoring clinical trial NCT00550082?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
- NCT06580314 · 880 participants · Phase 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia